Sato Vicki L

Insider·Vir Biotechnology, Inc.·VIR·Insider since 2025·Form 4 filings: 10
Trades YTD
2
Trades (12m)
8
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

8 transactions
02 Feb 2026
SOLD
$VIR
22,000
$7.71
S
02 Jan 2026
SOLD
$VIR
22,000
$5.93
S
01 Dec 2025
SOLD
$VIR
22,000
$6.00
S
03 Nov 2025
SOLD
$VIR
22,000
$5.64
S
01 Oct 2025
SOLD
$VIR
22,000
$5.84
S
02 Sep 2025
SOLD
$VIR
22,000
$4.99
S
01 Aug 2025
SOLD
$VIR
22,000
$4.99
S
01 Jul 2025
SOLD
$VIR
22,000
$5.10
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Vir Biotechnology, Inc.

last 30 days

No active insider cluster at Vir Biotechnology, Inc. in the last 30 days. L's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event L is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 12:44 UTC.